Literature DB >> 9577961

72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells.

G González-Avila1, C Iturria, F Vadillo, L Terán, M Selman, R Pérez-Tamayo.   

Abstract

In this study we examined the production of gelatinases A and B (MMP-2 and MMP-9), and their natural inhibitors TIMP-1 and TIMP-2 in cell lines derived from different histologic types of lung cancer. Gelatinolytic activity was measured by zymography and radiolabeled gelatin degradation. Immunocytochemistry and Western blot analysis were performed to corroborate the presence of immunoreactive MMP-2, MMP-9, TIMP-1 and TIMP-2 proteins. The highest gelatinolytic activity was identified in the cell extracts from a small-cell carcinoma cell line. MMP-9 was observed in all samples as a proenzyme, while MMP-2 was present as zymogen in the squamous-cell and in the small-cell carcinomas, and in its active form in one squamous-cell carcinoma cell line. TIMPs were also present in the neoplastic lung cell lines. TIMP-1 was observed in the media of all cells as a 21-kD band, and as TIMP-1 polymers with the exception of the small-cell carcinoma samples. TIMP-2 was found as higher-order molecular immunoreactive complexes that may correspond to proMMP-2/TIMP-2 complexes. These results demonstrate that lung neoplastic cells produce both MMP-2 and MMP-9 and their inhibitors, with the small-cell carcinoma cell extracts showing the highest enzymatic activity. This gelatinolytic activity fits well with the clinical metastatic behavior of this type of lung cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577961     DOI: 10.1159/000027989

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  11 in total

1.  Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.

Authors:  Keizo Kato; Akira Hara; Toshiya Kuno; Nami Kitaori; Zhi Huilan; Hideki Mori; Makoto Toida; Toshiyuki Shibata
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-22       Impact factor: 4.553

2.  Effects of antidiabetic drug metformin on the migration and invasion abilities of human pulmonary adenocarcinoma A549 cell line in vitro.

Authors:  Ning Wu; Hong-Jun Gu; Qiang Li
Journal:  J Thorac Dis       Date:  2010-06       Impact factor: 2.895

3.  Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.

Authors:  Jasti S Rao; Christopher Gondi; Chandramu Chetty; Subramanyam Chittivelu; Pushpa A Joseph; Sajani S Lakka
Journal:  Mol Cancer Ther       Date:  2005-09       Impact factor: 6.261

Review 4.  Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.

Authors:  Elzbieta Skrzydlewska; Mariola Sulkowska; Mariusz Koda; Stanislaw Sulkowski
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

Review 5.  Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals.

Authors:  Subash C Gupta; Ji Hye Kim; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

6.  Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathway.

Authors:  Jing Yang; Xiang-ru Kuang; Ping-tian Lv; Xi-xin Yan
Journal:  Tumour Biol       Date:  2014-09-20

Review 7.  Novel therapies for the treatment of small-cell lung cancer: a time for cautious optimism?

Authors:  Ruth E Board; Nick Thatcher; Paul Lorigan
Journal:  Drugs       Date:  2006       Impact factor: 9.546

8.  Relationship between matrix metalloproteinase 2 and lung cancer progression.

Authors:  Chun-Bao Guo; Shan Wang; Chun Deng; Dian-Liang Zhang; Fu-Ling Wang; Xian-Qing Jin
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  Increased collagenase activity in macrophages from bronchial lavage as a diagnostic marker of non-small cell lung cancer.

Authors:  Y Hakoda; Y Ito; A Nagate; K Minemura; K Utsumi; M Aoshima; K Ohyashiki
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

10.  A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.

Authors:  Quincy S C Chu; Bahram Forouzesh; Samira Syed; Monica Mita; Garry Schwartz; Joshua Cooper; Joshua Copper; Janet Curtright; Eric K Rowinsky
Journal:  Invest New Drugs       Date:  2007-01-20       Impact factor: 3.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.